Results per Page:
Transient transfection to make vaccines: cutting corners, or taking the express lane?
From The Kublin and Corey Labs, Vaccine and Infectious Disease Division
CAR T cell therapy targets HIV reservoirs to mitigate persistent HIV infection
From the Corey Lab, Vaccine and Infectious Disease Division
Non-traditional signaling: Memory T cells activate innate immunity
From the Zhu and Corey Lab, Vaccine and Infectious Disease Division
B cell kinetics during HSV-2 infection
From the Corey lab, Vaccine and Infectious Disease Division
Fred Hutch joins international COVID-19 vaccine effort
New clinical trials network will evaluate vaccines and antibodies to prevent COVID-19
Join Drs. Larry Corey and John Mascola for a discussion on COVID-19 vaccines
Hear from two global experts about how existing partnerships, networks and infrastructure can be used to develop, test and distribute vaccines safely and effectively, in record time
Fred Hutch, NIH experts outline plan for COVID-19 vaccines
In a Science perspective, experts urge multi-pronged, coordinated approach to successfully develop COVID-19 vaccines
Phylogenic trees inspire model for neurite measurement
From the Zhu lab, Vaccine and Infectious Disease Division
Despite early rise, longterm ART decreases HSV shedding
From the Corey lab, Vaccine and Infectious Disease Division
‘Don’t stop now’: an endgame for HIV/AIDS
HBO’s ‘Countdown to Zero,’ featuring Fred Hutch researchers, shows the pandemic remains, but fresh hope abounds
Countdown to Zero: The path to an HIV vaccine
A World AIDS Day Q&A with Fred Hutch’s Dr. Larry Corey, featured in HBO special report